Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
…, A Breithecker, M Haas, SKriechbaum… - Pulmonary …, 2018 - journals.sagepub.com
Riociguat is the treatment of choice for inoperable patients with chronic thromboembolic
pulmonary hypertension (CTEPH). We addressed here whether additional balloon pulmonary …
pulmonary hypertension (CTEPH). We addressed here whether additional balloon pulmonary …
N-terminal pro–B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
SDKriechbaum, CB Wiedenroth, JS Wolter… - The journal of heart and …, 2018 - Elsevier
Background Balloon pulmonary angioplasty (BPA) is an emerging interventional treatment
option for chronic thromboembolic pulmonary hypertension (CTEPH). The non-invasive …
option for chronic thromboembolic pulmonary hypertension (CTEPH). The non-invasive …
Angiopoietin-2 and outcome in patients with acute decompensated heart failure
Purpose Angiopoietin-2 (Ang-2) impairs endothelial integrity. The association of Ang-2 in
the presence of oedema and outcome of patients with acute decompensated heart failure (…
the presence of oedema and outcome of patients with acute decompensated heart failure (…
Non-invasive approach for evaluation of pulmonary hypertension using extracellular vesicle-associated small non-coding RNA
…, CB Wiedenroth,E Mayer, SDKriechbaum… - Biomolecules, 2019 - mdpi.com
Extracellular vesicles are released by numerous cell types of the human body under
physiological but also under pathophysiological conditions. They are important for cell–cell …
physiological but also under pathophysiological conditions. They are important for cell–cell …
Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary …
SDKriechbaum, CB Wiedenroth, K Peters, MA Barde… - Biomarkers, 2020 - Taylor & Francis
Purpose This study examined sST2, GDF-15, and galectin-3 as indicators of disease severity
and therapy response in chronic thromboembolic pulmonary hypertension (CTEPH). …
and therapy response in chronic thromboembolic pulmonary hypertension (CTEPH). …
Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience
SDKriechbaum, NF Boeder, L Gaede, M Arnold… - Clinical Research in …, 2020 - Springer
Aims To examine the clinical experience and practical use of the PASCAL transcatheter
valve repair system (Edwards Lifesciences, Irvine, CA, USA) and to report some of the first …
valve repair system (Edwards Lifesciences, Irvine, CA, USA) and to report some of the first …
[HTML][HTML]Aortic root remodeling leads to good valve stability in acute aortic dissection and preexistent root dilatation
T Kunihara, N Neumann, SDKriechbaum… - The Journal of thoracic …, 2016 - Elsevier
Objectives To evaluate the long-term results of aortic root remodeling in the setting of acute
aortic dissection type A (AADA). Methods Between October 1995 and May 2013, a total of …
aortic dissection type A (AADA). Methods Between October 1995 and May 2013, a total of …
[HTML][HTML]Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
SDKriechbaum, CB Wiedenroth,T Keller, JS Wolter… - PLoS …, 2018 - journals.plos.org
Aims Balloon pulmonary angioplasty (BPA) is an interventional treatment modality for inoperable
chronic thromboembolic pulmonary hypertension (CTEPH). Therapy monitoring, based …
chronic thromboembolic pulmonary hypertension (CTEPH). Therapy monitoring, based …
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension
…,C Troidl, C Liebetrau, SKriechbaum… - European …, 2021 - Eur Respiratory Soc
The aim of our study was to analyse the protein expression of cartilage intermediate layer
protein (CILP)1 in a mouse model of right ventricular (RV) pressure overload and to evaluate …
protein (CILP)1 in a mouse model of right ventricular (RV) pressure overload and to evaluate …
[HTML][HTML]Pregnancy-associated plasma protein A–a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
SDKriechbaum, F Rudolph… - Respiratory …, 2020 - respiratory-research.biomedcentral …
In chronic thromboembolic pulmonary hypertension (CTEPH) impaired pulmonary hemodynamics
lead to right heart failure. Natriuretic peptides reflect hemodynamic disease severity. …
lead to right heart failure. Natriuretic peptides reflect hemodynamic disease severity. …